Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sisonke: Ad26.COV2.S in South African HCWs
NCT04838795Phase 3Completed
- Sponsor
- Wits Health Consortium
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19), sponsored by Wits Health Consortium. Started Feb 2021; status: completed.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04838795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838795.